Back to search
Multiple Myleoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Multiple Myleoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Multiple Myleoma trials you may qualify forThe primary purpose of the study is to evaluate whether biweekly administered XEMBIFY® plus Standard Medical Treatment (SMT) over a one-year period will reduce…
All subjects will receive GR1803 injection until intolerable toxicity or investigator-assessed disease progression occurs (except in cases of disease progressio…
This study is a single-arm, investigator-initiated clinical trial. The primary objective is to evaluate the safety and preliminary efficacy of administering uni…
The goal of this clinical trial is to evaluate the efficacy of Teclistamab (Te) and autologous lymphocyte infusions (ALI) in relapse refractory multiple myeloma…